BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34735311)

  • 41. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
    Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
    Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of Ki-67 proliferation index and 18-fluorodeoxyglucose uptake in colorectal incidental lesions detected by positron emission tomography-computed tomography.
    Güreşci S; Özmen Ö; Uzman M; Şimşek G; Tatci E; Gökçek A; Yeniova AÖ
    Turk J Med Sci; 2016 Jun; 46(4):1182-7. PubMed ID: 27513423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.
    Shim JH; O JH; Oh SI; Yoo HM; Jeon HM; Park CH; Kim SH; Song KY
    J Gastrointest Surg; 2012 Oct; 16(10):1847-53. PubMed ID: 22752472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Background Colonic 18F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma.
    Lee KE; Moon CM; Yoon HJ; Kim BS; Chang JY; Son HM; Ryu MS; Kim SE; Shim KN; Jung HK; Jung SA
    PLoS One; 2016; 11(8):e0160886. PubMed ID: 27509022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
    Brown AM; Lindenberg ML; Sankineni S; Shih JH; Johnson LM; Pruthy S; Kurdziel KA; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Abdom Imaging; 2015 Oct; 40(8):3222-9. PubMed ID: 26239399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etiology and significance of incidentally detected focal colonic uptake on FDG PET/CT.
    Purandare NC; Gawade SK; Puranik AD; Agrawal A; Shah S; Rangarajan V
    Indian J Radiol Imaging; 2012 Oct; 22(4):260-6. PubMed ID: 23833416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C; Lin M; Chicco A; Benson R
    Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
    Hwang JP; Woo SK; Yoon SY; Jeong SY
    Ann Nucl Med; 2015 Feb; 29(2):157-63. PubMed ID: 25358843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
    Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
    Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDG uptake in colonic villous adenomas.
    Arslan N; Dehdashti F; Siegel BA
    Ann Nucl Med; 2005 Jun; 19(4):331-4. PubMed ID: 16097645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).
    Hirakawa T; Kato J; Okumura Y; Hori K; Takahashi S; Suzuki H; Akita M; Higashi R; Saito S; Kaji E; Uraoka T; Hiraoka S; Yamamoto K
    J Gastroenterol; 2012 Feb; 47(2):127-35. PubMed ID: 21983928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnostic value of water enema (18)F-fluorodexyglucose positron emission tomography and computed tomography in incidental finding of hypermetabolism focus in the colorectum].
    Zhang Z; Lyu Q; Chen F; Zhang J; Lu D; Hu P; Ma L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Mar; 17(3):239-44. PubMed ID: 24671811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
    Shyn PB; Madan R; Wu C; Erturk SM; Silverman SG
    AJR Am J Roentgenol; 2010 Feb; 194(2):414-21. PubMed ID: 20093604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of 18F-fluorodeoxyglucose PET/CT in histological grade of incidental colorectal adenoma.
    Peng Y; Xu N; Fu Y; Wang L; Chen F; Xue B; Lan J; Zheng X; Tang K
    Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):143-151. PubMed ID: 38860275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.
    Moletta L; Bissoli S; Fantin A; Passuello N; Valmasoni M; Sperti C
    BMC Cancer; 2018 May; 18(1):531. PubMed ID: 29728085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of 2-[
    Sekiguchi M; Kakugawa Y; Terauchi T; Matsumoto M; Saito H; Muramatsu Y; Saito Y; Matsuda T
    J Gastroenterol; 2016 Dec; 51(12):1122-1132. PubMed ID: 27021493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.